The Business of Biotech Conference convenes an audience of more than 400 biotechnology executives, entrepreneurs, venture capitalists, angel investors, and researchers from across the U.S. Learn more at https://www.moffitt.org/research-science/academic-and-industry-partnerships/office-of-innovation/business-of-biotech/.
GO2 for Lung Cancer’s Voices Summit will bring together people with lung cancer, caregivers, medical professionals, and supporters for education, training, connection, and direct advocacy with the federal government, the largest funder of cancer research. Learn more at https://na.eventscloud.com/ereg/index.php?eventid=769567&.
On March 20, 2024, PMC, the Congressional Personalized Medicine Caucus, and the Congressional Kidney Caucus co-hosted an educational briefing for Congressional staffers titled "Personalized Medicine and Kidney Care." The briefing examined how personalized medicine is benefiting kidney transplant patients now. It also highlighted key actions the research community is taking to improve the diagnosis and treatment of kidney disease through personalized medicine.
The 2024 Precision Medicine Tri-Conference will explore the latest research and technologies in precision medicine and precision health. Planned educational sessions include a keynote address and panel discussion on the state of innovation in diagnostic testing that will be chaired and moderated by PMC President Edward Abrahams as well as a presentation and panel discussion on implementing precision oncology that will be chaired and moderated by PMC Senior Vice President for Science Policy Daryl Pritchard. Learn more at www.triconference.com.
Participants in the Sepsis Alliance AMR Conference will explore innovative ideas, gain inspiration, and learn about practical technologies to manage sepsis and counteract the expanding challenge of antimicrobial resistance. Learn more at https://learn.sepsis.org/sepsis-alliance-amr-conference-2024?utm_source=Stakeholders&utm_medium=Stakeholders&utm_campaign=Stakeholders.
Dr. Marks will discuss the work of this important FDA center, which is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.
A virtual meeting of PMC's Public and Science Policy Committees will take place via Zoom on April 24, 2024, from 12:00 - 2:00 p.m. ET. PMC members will receive details and a registration link via email.
This summit will seek solutions to the specific economic gaps limiting the advancement of precision medicine. PMC Senior Vice President for Science Policy Daryl Pritchard will contribute to the discussions. Learn more at https://www.diaceutics.com/articles/multi-stakeholder-group-bring-a-unique-economic-solution-to-the-clinical-practice-gaps-holding-back-precision-medicine.
The Future of Biotechnology in Individualized Medicine Conference will explore the ongoing evolution of genomics from a tool for diagnostic breakthroughs to a driver of revolutionary therapeutics. Learn more at https://web.cvent.com/event/5ffdb74b-03b3-4ba9-ac99-7acde7751e61/websitePage:80210dd7-0a79-40ca-aedc-fb8b1fb6c56e.
During the Personalized Medicine Coalition's 16th Annual State of Personalized Medicine Luncheon, U.S. National Institutes of Health Director Monica Bertagnolli outlined her thoughts on the future of biomedical research and personalized medicine.
A virtual meeting of PMC's Public and Science Policy Committees will take place via Zoom on June 25, 2024, from 12:00 - 2:00 p.m. ET. PMC members will receive details and a registration link via email.
This hybrid workshop will examine how researchers could more meaningfully engage and sustain interactions with historically underrepresented communities in research to foster their participation in genomics and precision health studies. Learn more at https://www.nationalacademies.org/event/42785_07-2024_sustaining-community-engagement-in-genomics-research-a-workshop.